SBIR/STTR Research Award
IGF OT IGF MOBILE APPLICATION FOR PRESCRIPTION DRUG ABUSE EDUCATION MAPDE N DA PURPOSE TO EXERCISE OPTION PERIOD CONTRACT YEAR
Award amount
$500,000Program and phase
SBIR · Phase IIAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SICORE TECHNOLOGIES INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- ML2THEUJPXW9
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
The proposed Phase II effort shall Prepare the MAPDE application for use in primary care settings and long term use by patients for the purpose of prescription misuse risk reduction Develop the protocol and attain approvals for a pilot study to evaluate MAPDE over standard care in reducing risk of misuse and abuse To conduct a pilot study and analyze the results for misuse risk measures and find various indicators of the impact of MAPDE on misuse risk reduction in the primary care setting
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Enhanced Automated Cybersecurity Assessment
- Stakeholder Web-based Interrogable Federated Toolkit (SWIFT)
- CCA-SAFE: A Model-Assisted NDE Tool for Failure Analysis of Gold Contaminated Solder Joints
- Reduced Order Modeling for Aeroservoelastic Control and Analysis (RACA)
- Safety Analysis For Evaluating (SAFE) sUAS
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
26 SBIR/STTR records share this UEI (2005–2019). Reported award amounts total $9,043,975. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Homeland Security, Department of Transportation, Department of Health and Human Services, Department of Energy